Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 7 recruiting now early-phase tilt small index

Spine Metastases: early-phase trial registry

7 of 8 indexed Spine Metastases trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2,176 of 28,707 conditions by registered trial count.

8 US clinical trials · 7 currently recruiting · #2,176 of 28,707 conditions by registered trial count

Spine Metastases: 8 US clinical trials tracked, 7 recruiting.

Spine Metastases is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 7 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Baptist Health South Florida, running 3 of these trials.

Enrollment posture brief

Registry condition spine-metastases

OPEN 7 | RECR 88% | LATE 0 | EARLY 3 | RANK #2176 | SPON 3

Nearest open-share peer: Aortic Diseases (88% recruiting · 8 trials)

Spine Metastases (this)88%Activity, Motor75%Achalasia50%Abdominal Cancer25%Acne Scars - Mixed Atrophic 25%
Open-enrollment share among volume-matched conditions near Spine Metastases

Spine Metastases lists 7 open slots (88% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Spine Metastases on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Spine Metastases is recruiting above its size-band peers.

    7 of 8 indexed trials (87.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Spine Metastases research.

    Baptist Health South Florida accounts for 3 of 8 trials (37.5%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Most Spine Metastases trials plan to enrol fewer than 100 people.

    Median target enrolment is 63 among the 8 trials that report a genuine target (sentinel values excluded). 6 of those (75%) plan for fewer than 100 participants.

  4. Spine Metastases research is mostly interventional.

    7 interventional and 1 observational studies make up this index (87.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 22

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 2

Named interventions

Most-linked intervention names on Spine Metastases records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Radiofrequency Ablation (RFA) Radiation
1 trials
Radiotherapy alone Procedure
1 trials
Radiofrequency ablation and bone augmentation with radiotherapy Procedure
1 trials
SBRT to the spine Radiation
1 trials
Spine stereotactic body radiotherapy Radiation
1 trials
Brief pain inventory (BPI) Other
1 trials
QOL assessment Other
1 trials
Simulation CT Other
1 trials

US sites by state

Facility locations filed on Spine Metastases trials. A trial with sites in several states counts in each.

Florida 3 trials
Ohio 2 trials
Michigan 2 trials
New York 1 trials
New Jersey 1 trials
Minnesota 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Spine Metastases page

8 registered trials, 7 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Spine Metastases condition card totals 8 registered trials; most-linked intervention Radiofrequency Ablation (RFA); top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.